awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40749503-047C2ACA-0E97-4CF8-9398-A4B58EFF7082
Q40749503-047C2ACA-0E97-4CF8-9398-A4B58EFF7082
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40749503-047C2ACA-0E97-4CF8-9398-A4B58EFF7082
A two-dimensional biased coin design for dual-agent dose-finding trials.
P2860
Q40749503-047C2ACA-0E97-4CF8-9398-A4B58EFF7082
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40749503-047C2ACA-0E97-4CF8-9398-A4B58EFF7082
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
72fa7d230d042a8200ce028cc7a1e7260561f252
P2860
Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors.